Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

By Exec Edge Editorial Staff Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends ...

Colquitt County is rewriting the story of early literacy through strong community partnerships and the Archway Partnership.

Our review of Bay Area data shows that although San Francisco ranks high for social capital, there are significant variations ...

NAXS AB ( ($SE:NAXS) ) has shared an announcement. NAXS AB has repurchased 6,807 of its own shares on Nasdaq Stockholm between 15 and 19 December ...

"This is really about trying to put some, I guess you can call it accountability on this particular population as a result of the legislation," said Rob Miller.

AI is now a core part of business strategy, and leaders who understand how to use it can make faster decisions, drive ...

As a cybersecurity engineer, she leads efforts to uncover and seal the different ways in which data can fall into the wrong ...